Enhanced induction of a histamine-forming enzyme,histidine decarboxylase,in mice primed with NOD1 or NOD2 ligand in response to various Toll-like receptor agonists

Abstract

We investigated the immunopharmacological aspects of innate immune responses via Toll-like receptors (TLRs), NOD1 and NOD2, in terms of induction of the histamine-forming enzyme, histidine decarboxylase (HDC), activity in mice. Intravenous injection of TLR4-agonistic synthetic lipid A definitely induced HDC activity in the liver, spleen, and lungs, especially the lungs, in mice, where maximum activity was induced about 3 h after the injection of lipid A. The TLR2/6 agonistic synthetic diacyl-type lipopeptide FSL-1 and TLR3-agonistic poly I:C were also effective in inducing HDC, while the NOD2-agonistic synthetic muramyldipeptide (MDP) and NOD1-agonistic synthetic FK156 and FK565 exhibited only weak activities in this respect. Mice primed with intravenous injection of NOD1 or NOD2 agonists produced higher HDC activity following the 4—6 h later intravenous challenge with the above TLR agonists. Among the priming agents, FK565 exhibited the strongest activity, and it was effective via various administration routes — intraperitoneal, subcutaneous, intramuscular, as well as intravenous injection; furthermore, oral (gastric) administration was effective, although it needed a dose 10 times higher than that required for other administration routes. These findings suggest that HDC is induced in association with TLRs and NOD1/2, and that the newly formed histamine by the induced HDC might play important roles in the regulation of inflammatory and immune responses in various organs.

Keywords

histamine Toll-like receptors NOD1 NOD2 lipid A

References

Seidl PH , Schleifer KH Biological properties of peptidoglycan; Berlin : Walter de Gruyter, 1986; 1-436.

Girardin SE , Boneca IG , Carneiro Lam et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003; 300: 1584-1587.

Chamaillard M. , Hashimoto M. , Horie Y. et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003; 4: 702-707.

Inohara N. , Ogura Y. , Fontalba A. et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J Biol Chem 2003; 278: 5509-5512.

Girardin SE , Boneca IG , Viala J. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-8872.

Akira S. , Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.

Akira S. , Uematsu S. , Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.

Takeuchi O. , Kawai T. , Mühlradt PF et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13: 933-940.

Schneider E. , Rolli-Derkinderen M. , Arock M. , Dy M. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 2002; 23: 255-263.

10.

Endo Y. Induction of histidine and ornithine decarboxylase activities in mouse tissues by recombinant interleukin-1 and tumor necrosis factor. Biochem Pharmacol 1989; 38: 1287-1292.

11.

Endo Y. , Kikuchi T. , Takeda Y. , Nitta Y. , Rikiishi H. , Kumagai K. GM-CSF and G-CSF stimulate the synthesis of histamine and putrescine in the hematopoietic organs in vivo. Immunol Lett 1992; 33: 9-14.

12.

Wu X. , Yoshida A. , Sasano T. , Iwakura Y. , Endo Y. Histamine production via mast cell-independent induction of histidine decarboxylase in response to lipopolysaccharide and interleukin-1. Int Immunopharmacol 2004; 4: 513-520.

13.

Endo Y. , Nakamura M. , Nitta Y. , Kumagai K. Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor. Br J Pharmacol 1995; 114: 187-193.

14.

Parant M. , Parant F. , Vinit M. -A, Jupin C. , Noso Y. , Chedid L. Priming effect of muramyl peptides for induction by lipopolysaccharide of tumor necrosis factor production in mice. J Leukoc Biol 1990; 47: 164-169.

15.

Takada H. , Yokoyama S. , Yang S. Enhancement of endotoxin activity by muramyldipeptide. J Endotoxin Res 2002; 8: 337-342.

16.

Takada H. , Uehara A. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. Curr Pharm Design 2006 ; 12: 4163-4172.

17.

Shibata K. , Hasebe A. , Into T. , Yamada M. , Watanabe T. The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts . J Immunol 2000; 165: 6538-6544.

18.

Goto T. , Aoki H. The immunomodulatory activities of acylpeptides. In: Azuma I , Jollès G. , (eds) Immunostimulants: Now and Tomorrow. Berlin: Springer, 1987; 99-108.

19.

Endo Y. , Tabata T. , Kuroda H. , Tadano T. , Matsushima K. , Watanabe M. Induction of histidine decarboxylase in skeletal muscle in mice by electrical stimulation, prolonged walking and interleukin-1. J Physiol 1998; 509: 587-598.

20.

Funayama H. , Mayanagi H. , Takada H. , Endo Y. Elevation of histidine decarboxylase activity in the mandible of mice by Prevotella intermedia lipopolysaccharide and its augmentation by an aminobisphosphonate. Arch Oral Biol 2000; 45: 787-795.

21.

Takada H. , Galanos C. Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice. Infect Immun 1987; 55: 409-413.

22.

Nagao S. , Akagawa KS , Yamada K. , Yagawa K. , Tokunaga T. , Kotani S. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent. Microbiol Immunol 1990; 34: 323-335.

23.

Takada H. , Kotani S. Muramyl dipeptide and derivatives. In: Stewart-Tull DES., ed. The Theory and Practical Application of Adjuvants . Chichester, UK: John Wiley, 1995; 171-202.

24.

Uehara A. , Yang S. , Fujimoto Y. et al. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol 2005; 7: 53-61.

25.

Yang S. , Tamai R. , Akashi S. et al. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun 2001; 69: 2045-2053.

26.

Park J-H. , Kim Y-G. , McDonald C. et al. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 2007; 178: 2380-2386.